Bangladesh Approves Late-stage Trial of China's Sinovac Covid-19 Vaccine

Picture for illustration.

(Reuters)


Sinovac has been in search of volunteers exterior of China because the variety of coronavirus circumstances there has dwindled, stated a member of Bangladesh’s nationwide technical advisory committee to sort out COVID-19.

Reuters Dhaka
Final Up to date: July 20, 2020, 12:35 PM IST

Bangladesh has permitted the third-phase trial of a possible COVID-19 vaccine developed by China’s Sinovac Biotech Ltd, officers stated on Monday, as infections proceed to rise within the densely-populated South Asian nation.


Sinovac has been in search of volunteers exterior of China because the variety of coronavirus circumstances there has dwindled, stated a member of Bangladesh’s nationwide technical advisory committee to sort out COVID-19.

The Worldwide Centre for Diarrhoeal Illness Analysis, Bangladesh (ICDDR,B), will conduct the trial that would start subsequent month.

“We’ve given moral permission for the trial after reviewing the analysis protocol,” Mahmood Uz Jahan, director of the Bangladesh Medical Analysis Council (BMRC), advised Reuters.

“The protocol given to BMRC by ICDDR,B will likely be utilized to 4,200 volunteers. Half of them will get vaccinated.”

The trial could be performed in seven COVID-19 hospitals in Dhaka, Bangladesh’s capital, an ICDDR,B official stated on the situation of anonymity.

The nation had 204,525 confirmed coronavirus circumstances as of Sunday, with 2,618 deaths.

Sinovac stated this month it was beginning Section III trials of its potential coronavirus vaccine in Brazil.

A senior Bangladesh well being ministry official stated the nation hoped to get precedence in securing the vaccine ought to it show efficient within the trials.